BeiGene, Ltd.

SEC CIK #0001651308

BeiGene, Ltd. is registered with the U.S. Security and Exchange Commission. This page includes all SEC filing details as well as a list of any documents (S-1, Prospecuts, Current Reports, 8-K, 10K, Annual Reports) registered by BeiGene, Ltd..

Company Details
IRS Number (EIN)981209416 ( EIN # 98-1209416)
Reporting File Number001-37686
Fiscal Year End12-31
Date of Edgar Filing Update2019-04-02
SIC2834 [PHARMACEUTICAL PREPARATIONS]
Business AddressC/O MOURANT GOVERNANCE SERVICES (CAYMAN)
94 SOLARIS AVENUE, CAMANA BAY
GRAND CAYMAN E9 KY1-1108
Business Phone13459494123
Mailing AddressC/O MOURANT GOVERNANCE SERVICES (CAYMAN)
94 SOLARIS AVENUE, CAMANA BAY
GRAND CAYMAN E9 KY1-1108
Legal Entity Identifier 549300JFUK6FRD5MH739 [BeiGene, Ltd.]

Documents Filed
BeiGene, Ltd. SEC Filings RSS Feed

Form
Title
Date
8-K
2019-08-21 16:59:13
4
2019-08-14 16:08:26
4
2019-08-13 16:47:04
10-Q
2019-08-08 16:25:00
8-K
2019-08-08 16:19:23
4
2019-07-31 16:04:26
4
2019-07-09 19:23:59
4
2019-07-01 20:30:15
4
2019-07-01 20:28:48
4
2019-07-01 20:27:46
8-K
2019-06-20 16:43:24
4
2019-06-18 10:41:00
8-K/A
2019-06-18 06:37:26
8-K
2019-06-17 16:06:58
4
2019-06-11 08:25:45
4
2019-06-07 18:28:49
4
2019-06-07 16:18:17
4
2019-06-07 16:17:11
4
2019-06-07 16:15:49
4
2019-06-07 16:14:35
4
2019-06-07 16:13:23
4
2019-06-07 16:11:35
4
2019-06-07 16:08:27
4
2019-06-07 16:07:16
4
2019-06-07 16:05:14
8-K
2019-06-05 16:04:39
8-K
2019-06-03 16:03:56
4
2019-05-22 19:04:50
4
2019-05-22 19:03:21
4
2019-05-15 15:59:57
POSASR
2019-05-09 17:14:13
10-Q
2019-05-09 16:32:52
8-K
2019-05-09 16:16:23
4
2019-05-08 17:53:47
4
2019-05-02 16:08:49
4
2019-05-02 16:07:24
DEF 14A
2019-04-29 06:01:56
PRE 14A
2019-04-11 16:30:35
4
2019-04-10 18:41:49
8-K
2019-04-10 16:01:35
8-K
2019-04-02 16:25:12
4
2019-03-18 18:30:33
4
2019-03-14 16:25:30
4
2019-03-11 19:38:18
8-K
2019-03-07 16:05:07
4
2019-03-06 18:32:34
4
2019-03-05 16:08:15
10-K
2019-02-28 16:26:44
8-K
2019-02-27 16:23:53
SC 13G/A
2019-02-13 13:23:35
[ 2 ] Next->


0-50 of 343 Results
Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 |

© 2019 SEC.report
SEC CFR Title 17